Sharlin Consulting
  • Home
  • About / CV
  • Cases
  • Testimonials
  • Data Integrity
  • My 40 Classes
  • Contact Me
  • BLOG
  • Cell: 410.231.8900
Select Page

What Needs to be in an FDA Product Submission: A Reviewer’s Perspective

by Josh Sharlin | Dec 9, 2020 | FDA Expert Witness, What Needs to be in an FDA Product Submission: A Reviewer’s Perspective

Download Slides From Presentation An insightful presentation that explains how FDA reviewers examine a submission.It includes 3 practical ideas for how to create a better submission. These ideas apply to submissions for drugs, biologics, and medical devices. Over...

Recent Posts

  • What Needs to be in an FDA Product Submission: A Reviewer’s Perspective
  • FDA and DEA Litigation Briefing
  • FDA’s Requirements for Financial Disclosure

Archives

  • December 2020
  • January 2019

Categories

  • FDA and DEA Litigation Briefing
  • FDA Expert Witness
  • FDA Regulatory
  • FDA’s Requirements for Financial Disclosure
  • What Needs to be in an FDA Product Submission: A Reviewer’s Perspective

Tags

DEA DEA Litigation Briefing FDA FDA and DEA Litigation Briefing FDA Financial Disclosure fda Litigation Briefing FDA Product Submission FDA’s Requirements Financial Disclosure
  • Facebook

Sharlin Consulting ©2020 | Designed by Advantage Media Partners